MEM.ASX: Felix Registration Achieved in Vietnam and Cartridge Order

Felix Registration Achieved in Vietnam and Cartridge Order

Stock	Memphasys Ltd (MEM.ASX)
Release Time	20 Aug 2026, 8:48 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Memphasys Achieves Felix Registration in Vietnam, Triggers 600-Cartridge Order

Key Points

Vietnamese registration for the Felix System achieved in August 2026.
Registration triggers TMSC Vietnam's first commercial order of 600 Felix cartridges.
Total cartridges delivered or ordered for Vietnam now stand at 700.

Full Summary

Memphasys Limited has achieved registration for its Felix System in Vietnam, enabling full commercial sales. This milestone has triggered TMSC Vietnam's first commercial order of 600 Felix cartridges, adding to the 100 cartridges already delivered for testing. The order signifies the transition from clinical preparation to full commercial supply under a two-year A$530,000 agreement. TMSC Vietnam has also reported the first successful pregnancy following the use of Felix, demonstrating early clinical success. The company will now focus on converting early clinic engagement into broader adoption and recurring cartridge sales.

Outlook

Memphasys and TMSC Vietnam will focus on converting early clinic engagement into broader adoption and recurring cartridge sales. The achievement of registration on schedule, commencement of the first 600-cartridge commercial order, and the first reported pregnancy following use of Felix demonstrate tangible progress against the Vietnam market-entry plan.